Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow

Stem Cells

Volumn 25, Issue 6, 2007, Pages 1384-1392

  Baksh, Dolores ^a   Yao, Raphael ^a   Tuan, Rocky S ^a,b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Bone marrow stromal cells; Multidifferentiation; Perivascular cells

Indexed keywords

CD146 ANTIGEN; WNT PROTEIN;

ADIPOGENESIS; ANTIGEN EXPRESSION; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; GENETIC TRANSFECTION; GOLD STANDARD; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD;

ANTIGENS, CD146; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELLS; SIGNAL TRANSDUCTION; TRANSFECTION; UMBILICAL CORD; WNT PROTEINS;

EID: 34547122719     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0709     Document Type: Article

References (26)

1. Arinzeh TL, Peter SJ, Archambault MP et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am 2003;85-A:1927-1935.
2. Bruder SP, Kurth AA, Shea M et al. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 1998;16:155-162.
3. Mitchell KE, Weiss ML, Mitchell BM et al. Matrix cells from Wharton's jelly form neurons and glia. STEM CELLS 2003;21:50-60.
4. Sarugaser R, Lickorish D, Baksh D et al. Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. STEM CELLS 2005;23:220-229.
5. Wang HS, Hung SC, Peng ST et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. STEM CELLS 2004;22:1330-1337.
6. Fu YS, Cheng YC, Lin MY et al. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: Potential therapeutic application for Parkinsonism. STEM CELLS 2006;24:115-124.
7. Weiss ML, Medicetty S, Bledsoe AR et al. Human umbilical cord matrix stem cells: Preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. STEM CELLS 2006;24:781-792.
8. Weiss ML, Mitchell KE, Hix JE et al. Transplantation of porcine umbilical cord matrix cells into the rat brain. Exp Neurol 2003;182:288-299.
9. Davies JE. Human umbilical cord perivascular cells (HUCPVCs): A high yield source of MSCs. 12th Annual Meeting of the International Society of Cellular Therapy; May 4-7, 2006; Berlin, Germany.
10. Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 2003;18:696-704.
11. Haleem-Smith H, Derfoul A, Okafor C et al. Optimization of high-efficiency transfection of adult human mesenchymal stem cells. Mol Biotechnol 2005;30:9-20.
12. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991;78:55-62.
13. Duda DG, Cohen KS, di Tomaso E et al. Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: Implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy. J Clin Oncol 2006;24:1449-1453.
14. Blann AD, Woywodt A, Bertolini F et al. Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 2005;93:228-235.
15. Wu H, Riha GM, Yang H et al. Differentiation and proliferation of endothelial progenitor cells from canine peripheral blood mononuclear cells. J Surg Res 2005;126:193-198.
16. Baksh D, Davies JE, Zandstra PW. Adult human bone marrow-derived mesenchymal progenitor cells are capable of adhesion-independent survival and expansion. Exp Hematol 2003;31:723-732.
17. Weinand C, Pomerantseva I, Neville CM et al. Hydrogel-beta-TCP scaffolds and stem cells for tissue engineering bone. Bone 2006;38:555-563.
18. Wang Y, Kim UJ, Blasioli DJ et al. In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells. Biomaterials 2005;26:7082-7094.
19. Mauck RL, Byers BA, Yuan X et al. Regulation of Cartilaginous ECM Gene Transcription by Chondrocytes and MSCs in 3D Culture in Response to Dynamic Loading. Biomech Model Mechanobiol 2007;6:113-125.
20. Dannowski H, Bednarz J, Reszka R et al. Lipid-mediated gene transfer of acidic fibroblast growth factor into human corneal endothelial cells. Exp Eye Res 2005;80:93-101.
21. Aluigi M, Fogli M, Curti A et al. Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells. STEM CELLS 2006;24:454-461.
22. Hamada H, Kobune M, Nakamura K et al. Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci 2005;96:149-156.
23. Yue B, Lu B, Dai KR et al. BMP2 gene therapy on the repair of bone defects of aged rats. Calcif Tissue Int 2005;77:395-403.
24. McMahon JM, Conroy S, Lyons M et al. Gene transfer into rat mesenchymal stem cells: A comparative study of viral and nonviral vectors. Stem Cells Dev 2006;15:87-96.
25. Boland GM, Perkins G, Hall DJ et al. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 2004;93:1210-1230.
26. De Boer J, Siddappa R, Gaspar C et al. Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone 2004;34:818-826.